Pathogenic compound heterozygous ATP7B mutations with hypoceruloplasminaemia without clinical features of Wilson’s disease

The authors report a 44-year-old man with a history of attention deficit and hyperactivity disorder, obsessive compulsive behaviour, vocal tics, depression, and anxiety, in whom a compound heterozygous ATP7B mutation was found, associated with hypoceruloplasminemia, but without clinical or pathological manifestation of Wilson's disease (WD). Genetic testing revealed a compound heterozygous ATP7B mutation already described in WD, p.Met645Arg (C1934TG/c.51+4A→T). Hypoceruloplasminaemia was detected but no clinical manifestations (hepatic or central nervous system) of WD were present. The authors conclude that patients can carry a heterozygous mutation of the ATP7B gene that is associated with hypoceruloplasminaemia and display no overt clinical hepatic and/or central nervous system manifestations of WD.

[1]  Matthew T. Lorincz,et al.  Neurologic Wilson's disease , 2010, Annals of the New York Academy of Sciences.

[2]  M. T. Pellecchia,et al.  RNA analysis of consensus sequence splicing mutations: implications for the diagnosis of Wilson disease. , 2009, Genetic testing and molecular biomarkers.

[3]  M. Akil,et al.  Psychiatric and behavioral abnormalities in Wilson's disease. , 1995, Advances in neurology.

[4]  M. Scaff,et al.  Neurological manifestations in Wilson's disease: Report of 119 cases , 2006, Movement disorders : official journal of the Movement Disorder Society.

[5]  P. Bauer,et al.  High prevalence of the very rare wilson disease gene mutation Leu708Pro in the Island of Gran Canaria (Canary Islands, Spain): A genetic and clinical study , 2000, Hepatology.

[6]  H. Runz,et al.  Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease , 2010, Journal of Inherited Metabolic Disease.

[7]  L A Farrer,et al.  Novel ATP7B mutations causing Wilson disease in several Israeli ethnic groups , 1998, Human mutation.

[8]  G. Brewer.  Neurologically Presenting Wilson’s Disease , 2005, CNS drugs.

[9]  T. Gilliam,et al.  Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. , 1997, American journal of human genetics.

[10]  R Queralt,et al.  Mutation analysis of Wilson disease in the Spanish population – identification of a prevalent substitution and eight novel mutations in the ATP7B gene , 2005, Clinical genetics.

[11]  Y. Reddy,et al.  Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge! , 2008, Journal of the Neurological Sciences.

[12]  D. Cox,et al.  Sequence variation database for the Wilson disease copper transporter, ATP7B , 2007, Human mutation.

[13]  E. Barbosa,et al.  Wilson disease: Novel mutations in the ATP7B gene and clinical correlation in Brazilian patients , 2004, Human Mutation.

[14]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[15]  H. Schmidt.  Role of genotyping in Wilson's disease. , 2009, Journal of hepatology.

[16]  M. Behari,et al.  Genetics of Wilsons disease. , 2010, Parkinsonism & related disorders.

[17]  M. Tzetis,et al.  Genotype–phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B) , 2004, American journal of medical genetics. Part A.